Acer Therapeutics Inc. logo

Acer Therapeutics Inc.

NASDAQ:ACER

Overview | Financials
Company Name Acer Therapeutics Inc.
Symbol ACER
Currency USD
Price 0.66
Market Cap 0
Dividend Yield 0%
52-week-range 0.55 - 4.56
Industry Biotechnology
Sector Healthcare
CEO Mr. Christopher Schelling
Website https://www.acertx.com

An error occurred while fetching data.

About Acer Therapeutics Inc.

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium

Related Stocks

vTv Therapeutics Inc. logo

vTv Therapeutics Inc.

VTVT

13.87 USD

ARCA biopharma, Inc. logo

ARCA biopharma, Inc.

ABIO

28.8 USD

T2 Biosystems, Inc. logo

T2 Biosystems, Inc.

TTOO

0.345 USD

Immix Biopharma, Inc. logo

Immix Biopharma, Inc.

IMMX

2.18 USD

Financials

Numbers are in millions USD

Numbers are in millions USD